A Label-free Extracellular-vesicle Automated Purification System (LEAP System)
Award amount
$1,498,809Program and phase
SBIR · Phase IIAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- WELLSIM BIOMEDICAL TECHNOLOGIES INC
- Proposal award date
- 2022-07-01
- Contract end date
- 2024-06-30
- UEI
- FD9MPD9K3EC1
- Solicitation number
- PA21-259
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function characterization
- EXODOTS for diagnostic evaluation and monitoring of Alzheimer's disease
- Link phenotypic characteristics with gene expression profile of single cells at high throughput for drug discovery and cell therapy development
- Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization
- EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
7 SBIR/STTR records share this UEI (2021–2024). Reported award amounts total $4,515,698. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services